Abbot has issued a medical device correction for some of its glucose sensor products after identifying a manufacturing issue that can lead to falsely low glucose readings. The correction affects about ...
MedPage Today on MSN
Abbott Reports 7 Deaths Linked to Glucose Sensor Problem
Abbott issued a medical device correction for some of its glucose sensors after internal testing found that some sensors may ...
Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...
Abbott (NYSE:ABT) announced today that it issued a device correction for certain FreeStyle Libre 3 and Libre 3 Plus sensors ...
Abbott Laboratories said on Monday it has begun a correction in the United States for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitoring sensors after internal testing showed ...
Diabetes patients in the US will have greater flexibility in managing insulin delivery after Insulet announced its Omnipod ...
The US Food and Drug Administration (FDA) has cleared the Abbott Libre 2 and 3 continuous glucose monitoring (CGM) sensors for use during most imaging procedures, including MRI under certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback